New Key Statistics Module, Z-Score and F-Score
OTCPK:KKPCF Key Ratios
Market Cap $ M | 836.56 |
Enterprise Value $ M | 444.31 |
P/E(ttm) | 16.28 |
PE Ratio without NRI | 16.05 |
Forward PE Ratio | -- |
Price/Book | 0.91 |
Price/Sales | 1.81 |
Price/Free Cash Flow | 318.64 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.68 |
Revenue (TTM) $ M | 494.00 |
EPS (TTM) $ | 1.47 |
Beneish M-Score | -1.98 |
10-y EBITDA Growth Rate % | -6.20 |
5-y EBITDA Growth Rate % | -18.20 |
y-y EBITDA Growth Rate % | 33.10 |
EV-to-EBIT | 7.10 |
EV-to-EBITDA | 7.10 |
PEG | -- |
Shares Outstanding M | 37.87 |
Net Margin (%) | 11.14 |
Operating Margin % | 13.21 |
Pre-tax Margin (%) | 13.60 |
Quick Ratio | 4.72 |
Current Ratio | 5.62 |
ROA % (ttm) | 4.75 |
ROE % (ttm) | 5.75 |
ROIC % (ttm) | 8.75 |
Dividend Yield % | 4.51 |
Altman Z-Score | 4.99 |
KKPCF Number of Guru Trades
KKPCF Volume of Guru Trades
Gurus Latest Trades with OTCPK:KKPCF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:KKPCF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Kaken Pharmaceutical Co Ltd Insider Transactions
No Available Data
News about OTCPK:KKPCF
Total 0- 1